Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Biocept proposes follow-on

    Biocept Inc. (NASDAQ:BIOC), San Diego, Calif. Business: Diagnostic Date announced: 2016-08-12 Type: Follow-on To be raised: Up to $10 million Shares: TBD Price Prior: $0.58

    Published on 8/22/2016
  • Great Basin Scientific proposes follow-on

    Great Basin Scientific Inc. (NASDAQ:GBSN), Salt Lake City, Utah Business: Diagnostic, Infectious Date announced: 2016-08-15 Type: Follow-on To be raised: Up to $10 million Units: TBD Price Prior: $0.21 Underwriter: Roth…

    Published on 8/22/2016
  • Zosano proposes private placement of units

    Zosano Pharma Corp. (NASDAQ:ZSAN), Fremont, Calif. Business: Drug delivery, Musculoskeletal, Endocrine/Metabolic Date announced: 2016-08-16 Type: Private placement of units To be raised: About $7.5 million Units: 4.8 …

    Published on 8/22/2016
  • Acadia Pharmaceuticals completes follow-on

    Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), San Diego, Calif. Business: Neurology, Ophthalmic Date completed: 2016-08-09 Type: Follow-on Raised: $200 million Shares: 6.1 million Price: $33 Shares after offering: 120.1 …

    Published on 8/15/2016
  • Alimera Sciences completes follow-on

    Alimera Sciences Inc. (NASDAQ:ALIM), Alpharetta, Ga. Business: Ophthalmic Date completed: 2016-08-11 Type: Follow-on Raised: $25.2 million Shares: 18 million Price: $1.40 Shares after offering: 63.8 million Underwriters…

    Published on 8/15/2016
  • Amarin completes follow-on

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Cardiovascular, Endocrine/Metabolic Date completed: 2016-08-11 Type: Follow-on Raised: $60.1 million Shares: 21.1 million Price: $2.85 Shares after offering: 205…

    Published on 8/15/2016
  • Arrowhead completes private placement

    Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR), Pasadena, Calif. Business: Drug delivery Date completed: 2016-08-12 Type: Private placement Raised: $45 million Shares: 7.6 million Price: $5.90 Shares after offering: 68.4 …

    Published on 8/15/2016
  • BioMarin completes follow-on

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), San Rafael, Calif. Business: Musculoskeletal, Endocrine/Metabolic, Neurology Date completed: 2016-08-09 Type: Follow-on Raised: $720 million Shares: 7.5 million Price: $96 …

    Published on 8/15/2016
  • Cleave Biosciences completes venture financing

    Cleave Biosciences Inc., Burlingame, Calif. Business: Cancer Date completed: 2016-08-08 Type: Venture financing Raised: $37 million Investors: Celgene Corp.; Nextech Invest; Arcus Ventures; 5AM Ventures; Clarus; New …

    Published on 8/15/2016
  • Fate Therapeutics completes private placement

    Fate Therapeutics Inc. (NASDAQ:FATE), San Diego, Calif. Business: Gene/Cell therapy, Hematology, Cancer Date completed: 2016-08-08 Type: Private placement Raised: $10.3 million Shares: 5.3 million Price: $1.96 Shares …

    Published on 8/15/2016
  • Heron Therapeutics completes debt financing

    Heron Therapeutics Inc. (NASDAQ:HRTX), Redwood City, Calif. Business: Drug delivery, Neurology, Gastrointestinal Date completed: 2016-08-05 Type: Debt financing Raised: $50 million Investor: Tang Capital Partners Note: …

    Published on 8/15/2016
  • Humacyte completes venture financing

    Humacyte Inc., Research Triangle Park, N.C. Business: Cardiovascular, Renal Date completed: 2016-08-08 Type: Venture financing Raised: $9.9 million Investor: California Institute for Regenerative Medicine

    Published on 8/15/2016
  • ImmunoCellular completes follow-on

    ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date completed: 2016-08-09 Type: Follow-on Raised: $7.4 million Shares: 34.6 million Price: $0.16 Shares after offering: 127.8 million …

    Published on 8/15/2016
  • Innovus completes private placement of convertible notes

    Innovus Pharmaceuticals Inc. (OTCBB:INNV), San Diego, Calif. Business: Cancer, Dermatology Date completed: 2016-07-25 Type: Private placement of convertible notes Raised: $750,000 Shares outstanding prior: 87.2 million …

    Published on 8/15/2016
  • Metabolon completes venture financing

    Metabolon Inc., Durham, N.C. Business: Supply/Service, Diagnostic Date completed: 2016-08-11 Type: Venture financing Raised: $15 million Investor: Essex Woodlands Note: The company said it may raise an additional $10 …

    Published on 8/15/2016
  • Moderna Therapeutics completes venture financing

    Moderna Therapeutics Inc., Cambridge, Mass. Business: Infectious, Cancer, Cardiovascular Date completed: 2016-08-10 Type: Venture financing Raised: $140 million Investor: AstraZeneca plc

    Published on 8/15/2016
  • Noxopharm completes IPO

    Noxopharm Ltd. (ASX:NOX), Turramurra, Australia Business: Cancer Date completed: 2016-07-20 Type: IPO Raised: A$6 million ($4.5 million) Shares: 30 million Price: A$0.20 Shares after offering: 75.2 million

    Published on 8/15/2016
  • Nucorion Pharmaceuticals completes venture financing

    Nucorion Pharmaceuticals Inc., Business: Cancer Date completed: 2016-07-29 Type: Venture financing Raised: $5 million Investors: Silver River International Investment Ltd.; Ligand Pharmaceuticals Inc.

    Published on 8/15/2016
  • Omeros completes follow-on

    Omeros Corp. (NASDAQ:OMER), Seattle, Wash. Business: Neurology, Hematology, Ophthalmic Date completed: 2016-08-11 Type: Follow-on Raised: $40 million Shares: 3.5 million Price: $11.50 Shares after offering: 42.8 million…

    Published on 8/15/2016
  • ProMIS Neurosciences completes private placement of units

    ProMIS Neurosciences Inc. (TSX:PMN), Mississauga, Ontario Business: Neurology, Cancer, Diagnostic Date completed: 2016-08-10 Type: Private placement of units Raised: C$1 million ($759,466) Units: 7.4 million Price: C$0.…

    Published on 8/15/2016
  • Protagonist Therapeutics completes IPO

    Protagonist Therapeutics Inc. (NASDAQ:PTGX), Milpitas, Calif. Business: Autoimmune, Inflammation Date completed: 2016-08-10 Type: IPO Raised: $90 million Shares: 7.5 million Price: $12 Shares after offering: 16.3 …

    Published on 8/15/2016
  • Race Oncology completes IPO

    Race Oncology Ltd. (ASX:RAC), West Perth, Australia Business: Cancer Date completed: 2016-07-11 Type: IPO Raised: A$4.3 million ($3.2 million) Shares: 21.5 million Price: A$0.20 Shares after offering: 25.3 million

    Published on 8/15/2016
  • TapImmune completes private placement of units

    TapImmune Inc. (OTCQB:TPIV), Jacksonville, Fla. Business: Cancer, Infectious Date completed: 2016-08-11 Type: Private placement of units Raised: $2.5 million Units: 6.3 million Price: $0.40 (unit) Shares after offering:…

    Published on 8/15/2016
  • TapImmune completes warrant exercise

    TapImmune Inc. (OTCQB:TPIV), Jacksonville, Fla. Business: Cancer, Infectious Date completed: 2016-08-11 Type: Warrant exercise Raised: $6 million Shares: 12 million Price: $0.50 Shares after offering: 89.3 million …

    Published on 8/15/2016
  • Zurex Pharma completes venture financing

    Zurex Pharma Inc., Middleton, Wis. Business: Infectious Date completed: 2016-08-11 Type: Venture financing Raised: $6.2 million Investors: Existing investors; new investors

    Published on 8/15/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993